Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy B Niewold

Showing results (121-130 of 181) with videos related to

Pageof 19
Sort By:
Lupus Science & Medicine|April 9, 2026
Lectin pathway of complement in SLE: MAP-1 as a marker of haematological manifestations and elevated type I interferon activityLinnea Lindelöf, Peter Garred, Mun-Gwan Hong, et al.
Annals of the Rheumatic Diseases|May 19, 2011
Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosusLauren L Ritterhouse, Sherry R Crowe, Timothy B Niewold, et al.
ACR Open Rheumatology|November 29, 2019
Interferon Chemokine Score and Other Cytokine Measures Track With Changes in Disease Activity in Patients With Juvenile and Adult DermatomyositisCynthia S Crowson, Molly S Hein, Richard S Pendegraft, et al.
Arthritis and Rheumatism|May 21, 2011
Influenza vaccination responses in human systemic lupus erythematosus: impact of clinical and demographic featuresSherry R Crowe, Joan T Merrill, Evan S Vista, et al.
Plos One|December 24, 2011
Linkage of type I interferon activity and TNF-alpha levels in serum with sarcoidosis manifestations and ancestryNadera J Sweiss, Wei Zhang, Beverly S Franek, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|April 23, 2014
Efficacy Results of a 52-week Trial of Adalimumab in the Treatment of Refractory SarcoidosisNadera J Sweiss, Imre Noth, Mehdi Mirsaeidi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 16, 2024
TLR7/8 Activation in Immune Cells and Muscle by RNA-Containing Immune Complexes: Role in Inflammation and the Pathogenesis of MyositisYin Wu, Aditee Deshpande, Nicholas Geraci, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 1, 2017
Lupus-Associated Functional Polymorphism in PNP Causes Cell Cycle Abnormalities and Interferon Pathway Activation in Human Immune CellsYogita Ghodke-Puranik, Jessica M Dorschner, Danielle M Vsetecka, et al.
Cytokine|January 28, 2019
Novel genetic associations with interferon in systemic lupus erythematosus identified by replication and fine-mapping of trait-stratified genome-wide screenYogita Ghodke-Puranik, Molly Imgruet, Jessica M Dorschner, et al.
Arthritis Research & Therapy|January 25, 2013
Plasma levels of osteopontin identify patients at risk for organ damage in systemic lupus erythematosusOrnella J Rullo, Jennifer M P Woo, Miriam F Parsa, et al.
Pageof 19

Showing results (121-130 of 181) with videos related to

Sort By:
Pageof 19
Lupus Science & Medicine|April 9, 2026
Lectin pathway of complement in SLE: MAP-1 as a marker of haematological manifestations and elevated type I interferon activityLinnea Lindelöf, Peter Garred, Mun-Gwan Hong, et al.
Annals of the Rheumatic Diseases|May 19, 2011
Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosusLauren L Ritterhouse, Sherry R Crowe, Timothy B Niewold, et al.
ACR Open Rheumatology|November 29, 2019
Interferon Chemokine Score and Other Cytokine Measures Track With Changes in Disease Activity in Patients With Juvenile and Adult DermatomyositisCynthia S Crowson, Molly S Hein, Richard S Pendegraft, et al.
Arthritis and Rheumatism|May 21, 2011
Influenza vaccination responses in human systemic lupus erythematosus: impact of clinical and demographic featuresSherry R Crowe, Joan T Merrill, Evan S Vista, et al.
Plos One|December 24, 2011
Linkage of type I interferon activity and TNF-alpha levels in serum with sarcoidosis manifestations and ancestryNadera J Sweiss, Wei Zhang, Beverly S Franek, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|April 23, 2014
Efficacy Results of a 52-week Trial of Adalimumab in the Treatment of Refractory SarcoidosisNadera J Sweiss, Imre Noth, Mehdi Mirsaeidi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 16, 2024
TLR7/8 Activation in Immune Cells and Muscle by RNA-Containing Immune Complexes: Role in Inflammation and the Pathogenesis of MyositisYin Wu, Aditee Deshpande, Nicholas Geraci, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 1, 2017
Lupus-Associated Functional Polymorphism in PNP Causes Cell Cycle Abnormalities and Interferon Pathway Activation in Human Immune CellsYogita Ghodke-Puranik, Jessica M Dorschner, Danielle M Vsetecka, et al.
Cytokine|January 28, 2019
Novel genetic associations with interferon in systemic lupus erythematosus identified by replication and fine-mapping of trait-stratified genome-wide screenYogita Ghodke-Puranik, Molly Imgruet, Jessica M Dorschner, et al.
Arthritis Research & Therapy|January 25, 2013
Plasma levels of osteopontin identify patients at risk for organ damage in systemic lupus erythematosusOrnella J Rullo, Jennifer M P Woo, Miriam F Parsa, et al.
Pageof 19